By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CorePharma LLC 

215 Wood Avenue

Middlesex  New Jersey  08846  U.S.A.
Phone: 732-868-1090 Fax: 732-868-1091


SEARCH JOBS








Company News
CorePharma LLC Announces The Launch Of Dextroamphetamine Sulfate Tablets, USP 6/4/2014 11:23:04 AM
CorePharma LLC Launches Methylphenidate Hydrochloride Tablets USP 5/8/2014 9:20:45 AM
CorePharma LLC Addresses Violations in FDA Warning Letter 5/29/2013 9:43:16 AM
Shire Pharmaceuticals Group plc (SHPGY) Brings Legal Suit Against CorePharma LLC 5/18/2006 10:37:59 AM
Shire Pharmaceuticals Group plc (SHPGY) Release: CARBATROL(R) - Paragraph IV Notice Letter From CorePharma LLC 4/6/2006 12:41:31 PM
Magistrate Recommends Denial Of CollaGenex Pharmaceuticals, Inc. (CGPI) Motion For Preliminary Injunction To Prevent Launch Of Generic Forms Of Periostat By IVAX Corporation (IVX) And CorePharma LLC10/19/2005 5:13:03 PM
CollaGenex Pharmaceuticals, Inc. (CGPI) Seeks Immediate Injunctive Relief To Enforce Its Patent Following Court's Decision Allowing FDA To Approve ANDAs Covering Generic Versions Of Periostat10/19/2005 5:12:27 PM
CollaGenex Pharmaceuticals, Inc. (CGPI) Files Patent Infringement Claim Against IVAX Pharmaceuticals, Inc. (IVX) And CorePharma LLC10/19/2005 5:11:44 PM
CollaGenex Pharmaceuticals, Inc. (CGPI) Files Patent Infringement Claim Against IVAX Pharmaceuticals, Inc. (IVX) And CorePharma LLC10/19/2005 5:11:44 PM
CollaGenex Pharmaceuticals, Inc. (CGPI) Announces Restructuring Following FDA Approval Of IVAX Corporation (IVX) And CorePharma LLC's Generic Form Of Periostat; CollaGenex Will Cease All Sales And Marketing Activity With Respect To Periosta; Plans To Reduce Work Force10/19/2005 5:10:07 PM
12
//-->